Oppenheimer Asset Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-72,767
Closed -$730K 1167
2024
Q1
$730K Buy
72,767
+3,142
+5% +$29.2K 0.01% 757
2023
Q4
$648K Sell
69,625
-15,593
-18% -$161K 0.01% 806
2023
Q3
$1.08M Buy
85,218
+955
+1% +$13.1K 0.02% 667
2023
Q2
$1.2M Sell
84,263
-1,933
-2% -$27.1K 0.02% 655
2023
Q1
$1.29M Buy
86,196
+15,470
+22% +$234K 0.02% 613
2022
Q4
$1.05M Sell
70,726
-16,457
-19% -$269K 0.02% 672
2022
Q3
$1.44M Buy
87,183
+2,284
+3% +$46K 0.03% 544
2022
Q2
$1.78M Buy
84,899
+1,047
+1% +$21.4K 0.03% 502
2022
Q1
$1.97M Buy
83,852
+6,250
+8% +$153K 0.03% 535
2021
Q4
$2.11M Sell
77,602
-8,181
-10% -$219K 0.03% 533
2021
Q3
$2.44M Buy
85,783
+245
+0.3% +$7.47K 0.03% 471
2021
Q2
$2.58M Buy
85,538
+1,540
+2% +$45.4K 0.04% 457
2021
Q1
$2.14M Buy
+83,998
New +$2.15M 0.03% 496
2019
Q2
Sell
-8,172
Closed -$222K 1640
2019
Q1
$222K Sell
8,172
-30,484
-79% -$1.02M 0.01% 1010
2018
Q4
$1.27M Sell
38,656
-52,877
-58% -$2.13M 0.03% 498
2018
Q3
$4.27M Buy
91,533
+3,434
+4% +$158K 0.09% 249
2018
Q2
$3.81M Buy
88,099
+2,848
+3% +$136K 0.09% 264
2018
Q1
$4.74M Buy
85,251
+14,220
+20% +$779K 0.12% 219
2017
Q4
$3.06M Hold
71,031
0.08% 287
2017
Q3
$3.06M Sell
71,031
-874
-1% -$41.5K 0.08% 289
2017
Q2
$4.34M Sell
71,905
-750
-1% -$44.5K 0.12% 200
2017
Q1
$5.04M Buy
+72,655
New +$5.05M 0.14% 168

Other funds holding MD

Oppenheimer Asset Management's MD Position: Q2 2024 in Review

Oppenheimer Asset Management sold out of Pediatrix Medical (MD) in Q2 2024, closing a stake of 72,767 shares — an estimated $730K sold.

Oppenheimer Asset Management first reported a position in MD in Q1 2017 and held it in 22 quarters. The position peaked at $5.04M in Q1 2017. 227 funds tracked by Wall St. Rank hold MD as of Q2 2024.

  • Oppenheimer Asset Management reported no remaining Pediatrix Medical position as of Q2 2024 after selling out during the quarter.
  • Oppenheimer Asset Management sold 72,767 Pediatrix Medical shares in Q2 2024, an estimated $730K.
  • Oppenheimer Asset Management first reported a position in Pediatrix Medical in Q1 2017 and held it in 22 quarters.
  • Oppenheimer Asset Management's Pediatrix Medical position peaked at $5.04M in Q1 2017.
  • 227 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2024.

Based on Oppenheimer Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.